Home > Boards > US Listed > Biotechs > Minerva Neurosciences, Inc. (NERV)

NERV ready to break above the weekly cloud!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
TrendTrade2016 Member Profile
 
Followed By 413
Posts 12,360
Boards Moderated 3
Alias Born 03/22/16
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/19/2019 4:11:38 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 6/18/2019 4:46:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/17/2019 4:27:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 4:56:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 4:29:21 PM
Minerva Neurosciences to Present at JMP Securities Life Sciences Conference GlobeNewswire Inc. - 6/12/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2019 6:10:39 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2019 5:45:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2019 5:44:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2019 5:43:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2019 5:42:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2019 5:41:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2019 5:40:33 PM
Minerva Neurosciences to Present at Jefferies 2019 Global Healthcare Conference on June 4, 2019 GlobeNewswire Inc. - 5/29/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/21/2019 4:12:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 6:10:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/16/2019 8:39:48 AM
Minerva Neurosciences Announces Positive Top Line Results in Phase 2b Clinical Trial With Seltorexant (MIN-202) in Treatment ... GlobeNewswire Inc. - 5/13/2019 8:15:00 AM
Minerva Neurosciences Reports First Quarter 2019 Financial Results and Business Updates GlobeNewswire Inc. - 5/6/2019 7:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2019 7:02:44 AM
Minerva Neurosciences to Report First Quarter 2019 Financial Results and Business Updates on May 6, 2019 GlobeNewswire Inc. - 4/29/2019 8:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/17/2019 7:04:17 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/17/2019 7:01:46 AM
Withdrawal of Registration Statement (rw) Edgar (US Regulatory) - 4/11/2019 4:20:34 PM
Minerva Neurosciences Presents Pre-Clinical Data Suggesting a Mechanistic Role of Roluperidone in Addressing Negative Symptom... GlobeNewswire Inc. - 4/11/2019 8:30:00 AM
TrendTrade2016   Thursday, 05/24/18 03:27:49 PM
Re: None
Post # of 113 
NERV ready to break above the weekly cloud!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist